This will take effect July 16, 2012
Overview and Clinical Utility:
Effective July 16, 2012, Cytomegalovirus (CMV) IgM antibody testing will be performed on the Bioplex 2200 using a multiplex flow immunoassay methodology. CMV IgM is for the detection of human IgM antibodies to cytomegalovirus virus in human serum, as an aid in the determination of current or recent CMV infection.
Click Here to read more.